An issue brief by ASTHO and the Duke University Margolis Center for Health Policy that highlights considerations for state health officials as they look to maximize the benefits of COVID-19 therapeutics.
As COVID-19 emerged and spread in the U.S., people working and residing in long-term care facilities have experienced a significant burden of COVID-19 cases and deaths. As of Oct. 8, deaths associated with these facilities account for 40% ...
In anticipation of the upcoming presidential election in November, the Republican and Democratic National Committees released their platforms. These platforms provide an overview of values, policies, positions, and principles on various ...
With Omicron surges pushing jurisdictions to activate protocols for providing healthcare during crisis, it is important to incorporate disability inclusion into these crisis standards of care.
Public health data collection and surveillance systems by health departments are in dire need of modernization. Though the public health community began developing a path to modernization over the last decade, attention to this issue from ...
A New Normal for Public Health Agencies Association of state and territorial health officials, astho, states and territories, covid-19, covid-19 pandemic, immunization, vaccination, influenza vaccination, chronic disease, opioid epidemic, ...
Anticipating a rapid deployment of COVID-19 vaccines as they are authorized, the CDC developed COVID-19 Vaccination Program Operational Guidance in collaboration with state and local jurisdictions to outline how each jurisdiction will make ...
During the early spread of COVID-19, the National Rural Health Association senior vice president Brock Slabach stated: “Before the pandemic, rural hospitals were struggling for survival. COVID-19 has put a spotlight on the fractures that ...
As the Delta variant spreads across the country and increases the number of COVID-19 cases, the strain it is placing on the nation’s health system continues to grow. The surge of COVID-19 patients is contributing to a shortage of the ...
Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and millions of COVID-19 cases later, states and ...